Table 5 Effect of the intervention on lymphocyte subset concentrations.
Control (n = 25), mean (± SD) | NBIW (n = 25), mean (± SD) | Between-group comparison (week 4) | Within-group comparison | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
p | d or r | Effect size | p | ||||||||||
Control | NBIW | ||||||||||||
Number of T cells | /µL | Baseline | 1154.2 ± 281.7 | 0.3065 | − 0.14 | Small | 0.4926 | 0.9893 | |||||
Week 4 | 1203.0 ± 328.3 | 1177.6 ± 352.9 | |||||||||||
Number of CD4+ T cells | /µL | Baseline | 805.4 ± 200.5 | 0.8191 | − 0.03 | – | 0.7468 | 0.7064 | |||||
Week 4 | 819.0 ± 179.4 | 830.6 ± 266.8 | |||||||||||
Number of CD8+ T cells | /µL | Baseline | 198.0 ± 111.6 | 0.0395* | − 0.29 | Small | 0.0011** | 0.7672 | |||||
Week 4 | 230.2 ± 131.3 | 204.7 ± 123.3 | |||||||||||
CD4+:CD8+ ratio | – | Baseline | 5.209 ± 2.667 | 0.1829 | − 0.19 | Small | 0.0110* | 0.9250 | |||||
Week 4 | 4.800 ± 2.985 | 5.935 ± 4.399 | |||||||||||
Number of naive T cells | /µL | Baseline | 349.4 ± 142.5 | 0.0614 | − 0.26 | Small | 0.8401 | 0.1919 | |||||
Week 4 | 355.0 ± 139.2 | 343.5 ± 166.7 | |||||||||||
Number of memory T cells | /µL | Baseline | 456.0 ± 131.6 | 0.3529 | 0.15 | – | 0.5935 | 0.1065 | |||||
Week 4 | 464.0 ± 131.0 | 487.2 ± 171.4 | |||||||||||
N:M ratio | – | Baseline | 0.826 ± 0.354 | 0.1253 | − 0.18 | – | 0.8578 | 0.0070** | |||||
Week 4 | 0.833 ± 0.375 | 0.770 ± 0.334 | |||||||||||
Number of CD8+CD28+ T cells | /µL | Baseline | 145.8 ± 94.6 | 0.0561 | − 0.27 | Small | 0.0071** | 0.7982 | |||||
Week 4 | 168.6 ± 114.2 | 147.2 ± 99.7 | |||||||||||
Number of B cells | /µL | Baseline | 251.3 ± 114.8 | 0.1918 | − 0.18 | Small | 0.0061** | 0.0333* | |||||
Week 4 | 283.6 ± 133.8 | 268.2 ± 107.8 | |||||||||||
Number of natural killer cells | /µL | Baseline | 125.5 ± 69.6 | 0.2108 | − 0.18 | Small | 0.0979 | 0.3531 | |||||
Week 4 | 142.4 ± 69.2 | 130.4 ± 74.3 | |||||||||||